The reopening of fertility care services in the midst of the COVID-19 pandemic lead to numerous concerns that need immediate addressing. Companies in the cell & tissue preservation market are gaining awareness about these concerns to prevent the risk of cross-contamination and transmission at the fertility centers. Due to the novelty of the disease, there is a need for more information confirming an association of coronavirus with reproductive tissues, embryos, and gametes.
Cryobanking, being an essential service in fertility preservation, is linked with the risk of cross-contamination through the cryogenic mediums. Stakeholders are increasing research to find possible sources of cross-contamination through liquid nitrogen.
Cryopreservation holds potential to strongly benefit several areas of medicine by increasing the ease with which therapeutic cells, tissues, and organs can be stored. However, it has been found that extracellular ice directly damages tissues, either by puncturing or crushing cell membranes or by disrupting extracellular structures. In order to reduce the extent of ice-related damage, stakeholders are making use of cryopreservation protocols such as the CPAs (cryoprotective agents).
CPAs help to reduce the concentration of electrolytes and ice formation by hydrogen bonding with water molecules to prevent them from bonding to ice crystals. CPAs capable of crossing cell membranes are crucial in cryopreservation. The use of such molecules, termed penetrating CPAs (pCPAs), can substantially reduce cryoinjury.
The cell & tissue preservation market is projected to grow at a robust CAGR of 11.9% from 2021 to 2031. Giner Life Sciences - a privately-held company focused on the development and commercialization of oxygenated cell therapies, is pursuing new approaches in the application of oxygen for the preservation of transplant organs and clusters of cells inside implantable capsules. Companies in the cell & tissue preservation market are taking cues from such innovative approaches to develop transportation devices for a donated pancreas organ, which incorporates an on-demand oxygen generator.
Transportation device incorporating an on-demand oxygen generator holds potential to supply oxygen to the vasculature of the pancreas as soon as possible after it is donated.
There is a need for mid-range automation for cryopreservation. Companies in the cell & tissue preservation market are innovating in robot in order to meet this demand. Though dimethyl sulfoxide (DMSO) is considered as the gold standard for cryopreservation of mammalian cells and tissues, certain concentrations of DMSO can be toxic to cells. Thus, to mitigate potential toxicity problems, companies in the cell & tissue preservation market are increasing research on using different combinations of cryoprotective agents such as supplementing a lower concentration of DMSO with the glycerol or polypropylene glycol.
Moreover, companies are increasing efforts to introduce alternatives to DMSO such as biomimetic materials that are called the antifreeze protein or an ice-binding protein.
Analysts’ Viewpoint
Companies in the cell & tissue preservation market are adopting strategies to reduce the risks of cross-contamination at fertility centers, especially for oncofertility, amid the COVID-19 pandemic.. The cell & tissue preservation market is expected to reach US$ 10.04 Bn by 2031. However, one of the main limitations of current cryopreservation methods is the recovery rate of cells after freezing. Hence, companies should increase research in antifreeze proteins that have the potential to mimic the properties of synthetic polymers in cryopreservation methods. In addition, transportation devices incorporating on-demand oxygen generator are being publicized for use in organ transplant applications.
Cell & tissue preservation market to reach valuation Of US$ 10.04 Bn by 2031
Cell & tissue preservation market is projected to grow at a robust CAGR of 11.9% from 2021 to 2031
Cell & tissue preservation market is driven by increasing demand for regenerative medicines
The end-use segments in cell & tissue preservation market are biobanks, hospitals & others
Key players operating in the global cell & tissue market include Thermo Fisher Scientific, Inc., Lonza, BD, Merck KGaA, Cytiva, Agilent Technologies, Inc.
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary : Global Cell & Tissue Preservation Market
4. Market Overview
4.1. Introduction
4.1.1. Type Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Cell & Tissue Preservation Market Analysis and Forecast, 2017–2031
5. Key Insights
5.1. Key Industry Events (Mergers, Acquisitions, Collaborations, Approvals, etc.)
5.2. COVID-19 Pandemic Impact on Industry (value chain and short-/ mid-/ long-term impact)
5.3. Process Analysis
5.4. Top companies operating in Market Space
5.5. Applications of cell & tissue culture in drug development
5.6. Technological Advancements
6. Global Cell & Tissue Preservation Market Analysis and Forecast, by Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Global Cell & Tissue Preservation Market Value Forecast, by Type, 2017–2031
6.3.1. Cells
6.3.1.1. Mammalian Cells
6.3.1.2. Others (microorganisms and plant cells)
6.3.2. Tissues
6.3.2.1. Blood
6.3.2.2. Bone
6.3.2.3. Soft Tissues
6.3.2.4. Skin
6.3.2.5. Others
6.4. Global Cell & Tissue Preservation Market Attractiveness, by Type
7. Global Cell & Tissue Preservation Market Analysis and Forecast, by Application
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Global Cell & Tissue Preservation Market Value Forecast, by Application, 2017–2031
7.3.1. Therapeutics
7.3.2. Research & Development
7.3.3. Drug Discovery
7.3.4. Others (Cosmetics and Clinical trials)
7.4. Global Cell & Tissue Preservation Market Attractiveness, by Application
8. Global Cell & Tissue Preservation Market Analysis and Forecast, by Product
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Global Cell & Tissue Preservation Market Value Forecast, by Product, 2017–2031
8.3.1. Equipment
8.3.1.1. Freezers
8.3.1.2. Thawing Equipment
8.3.1.3. Refrigerators
8.3.1.4. Storage Systems
8.3.1.5. Others
8.3.2. Bio preservation media
8.3.2.1. Home-brew media
8.3.2.2. Pre-formulated media
8.3.3. Software
8.4. Global Cell & Tissue Preservation Market Attractiveness, by Product
9. Global Cell & Tissue Preservation Market Analysis and Forecast, by End-user
9.1. Introduction & Definition
9.2. Key Findings / Developments
9.3. Global Cell & Tissue Preservation Market Value Forecast, by End-user, 2017–2031
9.3.1. Biobanks
9.3.2. Hospitals
9.3.3. Others
9.4. Global Cell & Tissue Preservation Market Attractiveness, by End-user
10. Global Cell & Tissue Preservation Market Analysis and Forecast, by Region
10.1. Key Findings
10.2. Global Cell & Tissue Preservation Market Value Forecast, by Region
10.2.1. North America
10.2.2. Europe
10.2.3. Asia Pacific
10.2.4. Latin America
10.2.5. Middle East & Africa
10.3. Global Cell & Tissue Preservation Market Attractiveness, by Region
11. North America Cell & Tissue Preservation Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. North America Cell & Tissue Preservation Market Value Forecast, by Type, 2017–2031
11.2.1. Cells
11.2.1.1. Mammalian Cells
11.2.1.2. Others (microorganisms and plant cells)
11.2.2. Tissues
11.2.2.1. Blood
11.2.2.2. Bone
11.2.2.3. Soft Tissues
11.2.2.4. Skin
11.2.2.5. Others
11.3. North America Cell & Tissue Preservation Market Value Forecast, by Application, 2017–2031
11.3.1. Therapeutics
11.3.2. Research & Development
11.3.3. Drug Discovery
11.3.4. Others (Cosmetics and Clinical trials)
11.4. North America Cell & Tissue Preservation Market Value Forecast, by Product, 2017–2031
11.4.1. Equipment
11.4.1.1. Freezers
11.4.1.2. Thawing Equipment
11.4.1.3. Refrigerators
11.4.1.4. Storage Systems
11.4.1.5. Others
11.4.2. Bio preservation media
11.4.2.1. Home-brew media
11.4.2.2. Pre-formulated media
11.4.3. Software
11.5. North America Cell & Tissue Preservation Market Value Forecast, by End-user, 2017–2031
11.5.1. Biobanks
11.5.2. Hospitals
11.5.3. Others
11.6. North America Cell & Tissue Preservation Market Value Forecast, by Country, 2017–2031
11.6.1. U.S.
11.6.2. Canada
11.7. North America Cell & Tissue Preservation Market Attractiveness Analysis
11.7.1. By Type
11.7.2. By Application
11.7.3. By Product
11.7.4. By End-user
11.7.5. By Country
12. Europe Cell & Tissue Preservation Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Europe Cell & Tissue Preservation Market Value Forecast, by Type, 2017–2031
12.2.1. Cells
12.2.1.1. Mammalian Cells
12.2.1.2. Others (microorganisms and plant cells)
12.2.2. Tissues
12.2.2.1. Blood
12.2.2.2. Bone
12.2.2.3. Soft Tissues
12.2.2.4. Skin
12.2.2.5. Others
12.3. Europe Cell & Tissue Preservation Market Value Forecast, by Application, 2017–2031
12.3.1. Therapeutics
12.3.2. Research & Development
12.3.3. Drug Discovery
12.3.4. Others (Cosmetics and Clinical trials)
12.4. Europe Cell & Tissue Preservation Market Value Forecast, by Product, 2017–2031
12.4.1. Equipment
12.4.1.1. Freezers
12.4.1.2. Thawing Equipment
12.4.1.3. Refrigerators
12.4.1.4. Storage Systems
12.4.1.5. Others
12.4.2. Bio preservation media
12.4.2.1. Home-brew media
12.4.2.2. Pre-formulated media
12.4.3. Software
12.5. Europe Cell & Tissue Preservation Market Value Forecast, by End-user, 2017–2031
12.5.1. Biobanks
12.5.2. Hospitals
12.5.3. Others
12.6. Europe Cell & Tissue Preservation Market Value Forecast, by Country/Sub-region, 2017–2031
12.6.1. Germany
12.6.2. U.K.
12.6.3. France
12.6.4. Spain
12.6.5. Italy
12.6.6. Rest of Europe
12.7. Europe Cell & Tissue Preservation Market Attractiveness Analysis
12.7.1. By Type
12.7.2. By Application
12.7.3. By Product
12.7.4. By End-user
12.7.5. By Country/Sub-region
13. Asia Pacific Cell & Tissue Preservation Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Asia Pacific Cell & Tissue Preservation Market Value Forecast, by Type, 2017–2031
13.2.1. Cells
13.2.1.1. Mammalian Cells
13.2.1.2. Others (microorganisms and plant cells)
13.2.2. Tissues
13.2.2.1. Blood
13.2.2.2. Bone
13.2.2.3. Soft Tissues
13.2.2.4. Skin
13.2.2.5. Others
13.3. Asia Pacific Cell & Tissue Preservation Market Value Forecast, by Application, 2017–2031
13.3.1. Therapeutics
13.3.2. Research & Development
13.3.3. Drug Discovery
13.3.4. Others (Cosmetics and Clinical trials)
13.4. Asia Pacific Cell & Tissue Preservation Market Value Forecast, by Product, 2017–2031
13.4.1. Equipment
13.4.1.1. Freezers
13.4.1.2. Thawing Equipment
13.4.1.3. Refrigerators
13.4.1.4. Storage Systems
13.4.1.5. Others
13.4.2. Bio preservation media
13.4.2.1. Home-brew media
13.4.2.2. Pre-formulated media
13.4.3. Software
13.5. Asia Pacific Cell & Tissue Preservation Market Value Forecast, by End-user, 2017–2031
13.5.1. Biobanks
13.5.2. Hospitals
13.5.3. Others
13.6. Asia Pacific Cell & Tissue Preservation Market Value Forecast, by Country/Sub-region, 2017–2031
13.6.1. China
13.6.2. Japan
13.6.3. India
13.6.4. Australia & New Zealand
13.6.5. Rest of Asia Pacific
13.7. Asia Pacific Cell & Tissue Preservation Market Attractiveness Analysis
13.7.1. By Type
13.7.2. By Application
13.7.3. By Product
13.7.4. By End-user
13.7.5. By Country/Sub-region
14. Latin America Cell & Tissue Preservation Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Latin America Cell & Tissue Preservation Market Value Forecast, by Type, 2017–2031
14.2.1. Cells
14.2.1.1. Mammalian Cells
14.2.1.2. Others (microorganisms and plant cells)
14.2.2. Tissues
14.2.2.1. Blood
14.2.2.2. Bone
14.2.2.3. Soft Tissues
14.2.2.4. Skin
14.2.2.5. Others
14.3. Latin America Cell & Tissue Preservation Market Value Forecast, by Application, 2017–2031
14.3.1. Therapeutics
14.3.2. Research & Development
14.3.3. Drug Discovery
14.3.4. Others (Cosmetics and Clinical trials)
14.4. Latin America Cell & Tissue Preservation Market Value Forecast, by Product, 2017–2031
14.4.1. Equipment
14.4.1.1. Freezers
14.4.1.2. Thawing Equipment
14.4.1.3. Refrigerators
14.4.1.4. Storage Systems
14.4.1.5. Others
14.4.2. Bio preservation media
14.4.2.1. Home-brew media
14.4.2.2. Pre-formulated media
14.4.3. Software
14.5. Latin America Cell & Tissue Preservation Market Value Forecast, by End-user, 2017–2031
14.5.1. Biobanks
14.5.2. Hospitals
14.5.3. Others
14.6. Latin America Cell & Tissue Preservation Market Value Forecast, by Country/Sub-region, 2017–2031
14.6.1. Brazil
14.6.2. Mexico
14.6.3. Rest of Latin America
14.7. Market Attractiveness Analysis
14.7.1. By Type
14.7.2. By Application
14.7.3. By Product
14.7.4. By End-user
14.7.5. By Country
15. Middle East & Africa Cell & Tissue Preservation Market Analysis and Forecast
15.1. Introduction
15.1.1. Key Findings
15.2. Middle East & Africa Cell & Tissue Preservation Market Value Forecast, by Type, 2017–2031
15.2.1. Cells
15.2.1.1. Mammalian Cells
15.2.1.2. Others (microorganisms and plant cells)
15.2.2. Tissues
15.2.2.1. Blood
15.2.2.2. Bone
15.2.2.3. Soft Tissues
15.2.2.4. Skin
15.2.2.5. Others
15.3. Middle East & Africa Cell & Tissue Preservation Market Value Forecast, by Application, 2017–2031
15.3.1. Therapeutics
15.3.2. Research & Development
15.3.3. Drug Discovery
15.3.4. Others (Cosmetics and Clinical trials)
15.4. Middle East & Africa Cell & Tissue Preservation Market Value Forecast, by Product, 2017–2031
15.4.1. Equipment
15.4.1.1. Freezers
15.4.1.2. Thawing Equipment
15.4.1.3. Refrigerators
15.4.1.4. Storage Systems
15.4.1.5. Others
15.4.2. Bio preservation media
15.4.2.1. Home-brew media
15.4.2.2. Pre-formulated media
15.4.3. Software
15.5. Middle East & Africa Cell & Tissue Preservation Market Value Forecast, by End-user, 2017–2031
15.5.1. Biobanks
15.5.2. Hospitals
15.5.3. Others
15.6. Middle East & Africa Cell & Tissue Preservation Market Value Forecast, by Country/Sub-region, 2017–2031
15.6.1. GCC Countries
15.6.2. South Africa
15.6.3. Rest of Middle East & Africa
15.7. Middle East & Africa Cell & Tissue Preservation Market Attractiveness Analysis
15.7.1. By Type
15.7.2. By Application
15.7.3. By Product
15.7.4. By End-user
15.7.5. By Country/Sub-region
16. Competition Landscape
16.1. Market Share Analysis, by Company (2019)
16.2. Company Profiles
16.2.1. Thermo Fisher Scientific, Inc.
16.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.1.2. Product Portfolio
16.2.1.3. SWOT Analysis
16.2.1.4. Strategic Overview
16.2.2. Lonza
16.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.2.2. Product Portfolio
16.2.2.3. SWOT Analysis
16.2.2.4. Strategic Overview
16.2.3. BD
16.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.3.2. Product Portfolio
16.2.3.3. SWOT Analysis
16.2.3.4. Strategic Overview
16.2.4. Merck KGaA
16.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.4.2. Product Portfolio
16.2.4.3. SWOT Analysis
16.2.4.4. Strategic Overview
16.2.5. Cytiva
16.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.5.2. Product Portfolio
16.2.5.3. SWOT Analysis
16.2.5.4. Strategic Overview
16.2.6. Agilent Technologies, Inc.
16.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.6.2. Product Portfolio
16.2.6.3. SWOT Analysis
16.2.6.4. Strategic Overview
16.2.7. Avantor, Inc.
16.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.7.2. Product Portfolio
16.2.7.3. SWOT Analysis
16.2.7.4. Strategic Overview
16.2.8. FUJIFILM Irvine Scientific.
16.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.8.2. Product Portfolio
16.2.8.3. SWOT Analysis
16.2.8.4. Strategic Overview
16.2.9. BioLifeSolutions Inc.
16.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.9.2. Product Portfolio
16.2.9.3. SWOT Analysis
16.2.9.4. Strategic Overview
16.2.10. AMSBIO
16.2.10.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.10.2. Product Portfolio
16.2.10.3. SWOT Analysis
16.2.10.4. Strategic Overview
16.2.11. Princeton CryoTech
16.2.11.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.11.2. Product Portfolio
16.2.11.3. SWOT Analysis
16.2.11.4. Strategic Overview
16.2.12. STEMCELL Technologies Inc.
16.2.12.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.12.2. Product Portfolio
16.2.12.3. SWOT Analysis
16.2.12.4. Strategic Overview
16.2.13. LGC SeraCare
16.2.13.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.13.2. Product Portfolio
16.2.13.3. SWOT Analysis
16.2.13.4. Strategic Overview
16.2.14. Corning Incorporated
16.2.14.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.14.2. Product Portfolio
16.2.14.3. SWOT Analysis
16.2.14.4. Strategic Overview
16.2.15. CellGenix GmbH
16.2.15.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.15.2. Product Portfolio
16.2.15.3. SWOT Analysis
16.2.15.4. Strategic Overview
16.2.16. Others
16.2.16.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.16.2. Product Portfolio
16.2.16.3. SWOT Analysis
16.2.16.4. Strategic Overview
List of Tables
Table 01: Global Cell & Tissue Preservation Market Value (US$ Mn) Forecast, by Type, 2017–2031
Table 02: Global Cell & Tissue Preservation Market Value (US$ Mn) Forecast, by Cells, 2017–2031
Table 03: Global Cell & Tissue Preservation Market Value (US$ Mn) Forecast, by Tissues, 2017–2031
Table 04: Global Cell & Tissue Preservation Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 05: Global Cell & Tissue Preservation Market Value (US$ Mn) Forecast, by Product, 2017–2031
Table 06: Global Cell & Tissue Preservation Market Value (US$ Mn) Forecast, by Equipment, 2017–2031
Table 07: Global Cell & Tissue Preservation Market Value (US$ Mn) Forecast, by Bio preservation media, 2017–2031
Table 08: Global Cell & Tissue Preservation Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 09: Global Cell & Tissue Preservation Market Value (US$ Mn) Forecast, by Region, 2017–2031
Table 10: North America Cell & Tissue Preservation Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 11: North America Cell & Tissue Preservation Market Value (US$ Mn) Forecast, by Type, 2017–2031
Table 12: North America Cell & Tissue Preservation Market Value (US$ Mn) Forecast, by Cells, 2017–2031
Table 13: North America Cell & Tissue Preservation Market Value (US$ Mn) Forecast, by Tissues, 2017–2031
Table 14: North America Cell & Tissue Preservation Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 15: North America Cell & Tissue Preservation Market Value (US$ Mn) Forecast, by Product, 2017–2031
Table 16: North America Cell & Tissue Preservation Market Value (US$ Mn) Forecast, by Equipment, 2017–2031
Table 17: North America Cell & Tissue Preservation Market Value (US$ Mn) Forecast, by Bio preservation media, 2017–2031
Table 18: North America Cell & Tissue Preservation Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 19: Europe Cell & Tissue Preservation Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 20: Europe Cell & Tissue Preservation Market Value (US$ Mn) Forecast, by Type, 2017–2031
Table 21: Europe Cell & Tissue Preservation Market Value (US$ Mn) Forecast, by Cells, 2017–2031
Table 22: Europe Cell & Tissue Preservation Market Value (US$ Mn) Forecast, by Tissues, 2017–2031
Table 23: Europe Cell & Tissue Preservation Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 24: Europe Cell & Tissue Preservation Market Value (US$ Mn) Forecast, by Product, 2017–2031
Table 25: Europe Cell & Tissue Preservation Market Value (US$ Mn) Forecast, by Equipment, 2017–2031
Table 26: Europe Cell & Tissue Preservation Market Value (US$ Mn) Forecast, by Bio preservation media, 2017–2031
Table 27: Europe Cell & Tissue Preservation Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 28: Asia Pacific Cell & Tissue Preservation Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 29: Asia Pacific Cell & Tissue Preservation Market Value (US$ Mn) Forecast, by Type, 2017–2031
Table 30: Asia Pacific Cell & Tissue Preservation Market Value (US$ Mn) Forecast, by Cells, 2017–2031
Table 31: Asia Pacific Cell & Tissue Preservation Market Value (US$ Mn) Forecast, by Tissues, 2017–2031
Table 32: Asia Pacific Cell & Tissue Preservation Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 33: Asia Pacific Cell & Tissue Preservation Market Value (US$ Mn) Forecast, by Product, 2017–2031
Table 34: Asia Pacific Cell & Tissue Preservation Market Value (US$ Mn) Forecast, by Equipment, 2017–2031
Table 35: Asia Pacific Cell & Tissue Preservation Market Value (US$ Mn) Forecast, by Bio preservation media, 2017–2031
Table 36: Asia Pacific Cell & Tissue Preservation Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 37: Latin America Cell & Tissue Preservation Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 38: Latin America Cell & Tissue Preservation Market Value (US$ Mn) Forecast, by Type, 2017–2031
Table 39: Latin America Cell & Tissue Preservation Market Value (US$ Mn) Forecast, by Cells, 2017–2031
Table 40: Latin America Cell & Tissue Preservation Market Value (US$ Mn) Forecast, by Tissues, 2017–2031
Table 41: Latin America Cell & Tissue Preservation Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 42: Latin America Cell & Tissue Preservation Market Value (US$ Mn) Forecast, by Product, 2017–2031
Table 43: Latin America Cell & Tissue Preservation Market Value (US$ Mn) Forecast, by Equipment, 2017–2031
Table 44: Latin America Cell & Tissue Preservation Market Value (US$ Mn) Forecast, by Bio preservation media, 2017–2031
Table 45: Latin America Cell & Tissue Preservation Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 46: Middle East & Africa Cell & Tissue Preservation Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 47: Middle East & Africa Cell & Tissue Preservation Market Value (US$ Mn) Forecast, by Type, 2017–2031
Table 48: Middle East & Africa Cell & Tissue Preservation Market Value (US$ Mn) Forecast, by Cells, 2017–2031
Table 49: Middle East & Africa Cell & Tissue Preservation Market Value (US$ Mn) Forecast, by Tissues, 2017–2031
Table 50: Middle East & Africa Cell & Tissue Preservation Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 51: Middle East & Africa Cell & Tissue Preservation Market Value (US$ Mn) Forecast, by Product, 2017–2031
Table 52: Middle East & Africa Cell & Tissue Preservation Market Value (US$ Mn) Forecast, by Equipment, 2017–2031
Table 53: Middle East & Africa Cell & Tissue Preservation Market Value (US$ Mn) Forecast, by Bio preservation media, 2017–2031
Table 54: Middle East & Africa Cell & Tissue Preservation Market Value (US$ Mn) Forecast, by End-user, 2017–2031
List of Figures
Figure 01: Global Cell & Tissue Preservation Market Value (US$ Mn) Forecast, 2017–2031
Figure 02: Global Cell & Tissue Preservation Market Value Share, by Type, 2020
Figure 03: Global Cell & Tissue Preservation Market Value Share, by Product, 2020
Figure 04: Global Cell & Tissue Preservation Market Value Share, by Application, 2020
Figure 05: Global Cell & Tissue Preservation Market Value Share, by Region, 2020
Figure 06: Global Cell & Tissue Preservation Market Value Share, by End-user, 2020
Figure 07: Global Cell & Tissue Preservation Market Value Share Analysis, by Type, 2020 and 2031
Figure 08: Global Cell & Tissue Preservation Market Attractiveness Analysis, by Type, 2021–2031
Figure 09: Global Cell & Tissue Preservation Market Value (US$ Mn), by Cells, 2017–2031
Figure 10: Global Cell & Tissue Preservation Market Value (US$ Mn), by Tissues, 2017–2031
Figure 11: Global Cell & Tissue Preservation Market Value Share Analysis, by Application, 2020 and 2031
Figure 12: Global Cell & Tissue Preservation Market Attractiveness Analysis, by Application, 2021–2031
Figure 13: Global Cell & Tissue Preservation Market Value (US$ Mn), by Therapeutics, 2017–2031
Figure 14: Global Cell & Tissue Preservation Market Value (US$ Mn), by Research & Development, 2017–2031
Figure 15: Global Cell & Tissue Preservation Market Value (US$ Mn), by Drug Discovery, 2017–2031
Figure 16: Global Cell & Tissue Preservation Market Value (US$ Mn), by Others (Cosmetics and Clinical trials), 2017–2031
Figure 17: Global Cell & Tissue Preservation Market Value Share Analysis, by Product, 2020 and 2031
Figure 18: Global Cell & Tissue Preservation Market Attractiveness Analysis, by Product, 2021–2031
Figure 19: Global Cell & Tissue Preservation Market Value (US$ Mn), by Equipment, 2017–2031
Figure 20: Global Cell & Tissue Preservation Market Value (US$ Mn), by Bio Preservation Media, 2017–2031
Figure 21: Global Cell & Tissue Preservation Market Value (US$ Mn), by Software, 2017–2031
Figure 22: Global Cell & Tissue Preservation Market Value Share Analysis, by End-user, 2020 and 2031
Figure 23: Global Cell & Tissue Preservation Market Attractiveness Analysis, by End-user, 2021–2031
Figure 24: Global Cell & Tissue Preservation Market Value (US$ Mn), by Biobanks, 2017–2031
Figure 25: Global Cell & Tissue Preservation Market Value (US$ Mn), by Hospitals, 2017–2031
Figure 26: Global Cell & Tissue Preservation Market Value (US$ Mn), by Others, 2017–2031
Figure 27: Global Cell & Tissue Preservation Market Value Share Analysis, by Region, 2020 and 2031
Figure 28: Global Cell & Tissue Preservation Market Attractiveness Analysis, by Region, 2021–2031
Figure 29: North America Cell & Tissue Preservation Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031
Figure 30: North America Cell & Tissue Preservation Market Value Share, by Country/Sub-region, 2020–2031
Figure 31: North America Cell & Tissue Preservation Market Attractiveness, by Country/Sub-region, 2021–2031
Figure 32: North America Cell & Tissue Preservation Market Value Share Analysis, by Type, 2020 and 2031
Figure 33: North America Cell & Tissue Preservation Market Attractiveness Analysis, by Type, 2021–2031
Figure 34: North America Cell & Tissue Preservation Market Value Share Analysis, by Application, 2020 and 2031
Figure 35: North America Cell & Tissue Preservation Market Attractiveness Analysis, by Application, 2021–2031
Figure 36: North America Cell & Tissue Preservation Market Value Share Analysis, by Product, 2020 and 2031
Figure 37: North America Cell & Tissue Preservation Market Attractiveness Analysis, by Product, 2021–2031
Figure 38: North America Cell & Tissue Preservation Market Value Share Analysis, by End-user, 2020 and 2031
Figure 39: North America Cell & Tissue Preservation Market Attractiveness Analysis, by End-user, 2021–2031
Figure 40: Europe Cell & Tissue Preservation Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031
Figure 41: Europe Cell & Tissue Preservation Market Value Share, by Country/Sub-region, 2020–2031
Figure 42: Europe Cell & Tissue Preservation Market Attractiveness, by Country/Sub-region, 2021–2031
Figure 43: Europe Cell & Tissue Preservation Market Value Share Analysis, by Type, 2020 and 2031
Figure 44: Europe Cell & Tissue Preservation Market Attractiveness Analysis, by Type, 2021–2031
Figure 45: Europe Cell & Tissue Preservation Market Value Share Analysis, by Application, 2020 and 2031
Figure 46: Europe Cell & Tissue Preservation Market Attractiveness Analysis, by Application, 2021–2031
Figure 47: Europe Cell & Tissue Preservation Market Value Share Analysis, by Product, 2020 and 2031
Figure 48: Europe Cell & Tissue Preservation Market Attractiveness Analysis, by Product, 2021–2031
Figure 49: Europe Cell & Tissue Preservation Market Value Share Analysis, by End-user, 2020 and 2031
Figure 50: Europe Cell & Tissue Preservation Market Attractiveness Analysis, by End-user, 2021–2031
Figure 51: Asia Pacific Cell & Tissue Preservation Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031
Figure 52: Asia Pacific Cell & Tissue Preservation Market Value Share, by Country/Sub-region, 2020–2031
Figure 53: Asia Pacific Cell & Tissue Preservation Market Attractiveness, by Country/Sub-region, 2021–2031
Figure 54: Asia Pacific Cell & Tissue Preservation Market Value Share Analysis, by Type, 2020 and 2031
Figure 55: Asia Pacific Cell & Tissue Preservation Market Attractiveness Analysis, by Type, 2021–2031
Figure 56: Asia Pacific Cell & Tissue Preservation Market Value Share Analysis, by Application, 2020 and 2031
Figure 57: Asia Pacific Cell & Tissue Preservation Market Attractiveness Analysis, by Application, 2021–2031
Figure 58: Asia Pacific Cell & Tissue Preservation Market Value Share Analysis, by Product, 2020 and 2031
Figure 59: Asia Pacific Cell & Tissue Preservation Market Attractiveness Analysis, by Product, 2021–2031
Figure 60: Asia Pacific Cell & Tissue Preservation Market Value Share Analysis, by End-user, 2020 and 2031
Figure 61: Asia Pacific Cell & Tissue Preservation Market Attractiveness Analysis, by End-user, 2021–2031
Figure 62: Latin America Cell & Tissue Preservation Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031
Figure 63: Latin America Cell & Tissue Preservation Market Value Share, by Country/Sub-region, 2020–2031
Figure 64: Latin America Cell & Tissue Preservation Market Attractiveness, by Country/Sub-region, 2021–2031
Figure 65: Latin America Cell & Tissue Preservation Market Value Share Analysis, by Type, 2020 and 2031
Figure 66: Latin America Cell & Tissue Preservation Market Attractiveness Analysis, by Type, 2021–2031
Figure 67: Latin America Cell & Tissue Preservation Market Value Share Analysis, by Application, 2020 and 2031
Figure 68: Latin America Cell & Tissue Preservation Market Attractiveness Analysis, by Application, 2021–2031
Figure 69: Latin America Cell & Tissue Preservation Market Value Share Analysis, by Product, 2020 and 2031
Figure 70: Latin America Cell & Tissue Preservation Market Attractiveness Analysis, by Product, 2021–2031
Figure 71: Latin America Cell & Tissue Preservation Market Value Share Analysis, by End-user, 2020 and 2031
Figure 72: Latin America Cell & Tissue Preservation Market Attractiveness Analysis, by End-user, 2021–2031
Figure 73: Middle East & Africa Cell & Tissue Preservation Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031
Figure 74: Middle East & Africa Cell & Tissue Preservation Market Value Share, by Country/Sub-region, 2020–2031
Figure 75: Middle East & Africa Cell & Tissue Preservation Market Attractiveness, by Country/Sub-region, 2021–2031
Figure 76: Middle East & Africa Cell & Tissue Preservation Market Value Share Analysis, by Type, 2020 and 2031
Figure 77: Middle East & Africa Cell & Tissue Preservation Market Attractiveness Analysis, by Type, 2021–2031
Figure 78: Middle East & Africa Cell & Tissue Preservation Market Value Share Analysis, by Application, 2020 and 2031
Figure 79: Middle East & Africa Cell & Tissue Preservation Market Attractiveness Analysis, by Application, 2021–2031
Figure 80: Middle East & Africa Cell & Tissue Preservation Market Value Share Analysis, by Product, 2020 and 2031
Figure 81: Middle East & Africa Cell & Tissue Preservation Market Attractiveness Analysis, by Product, 2021–2031
Figure 82: Middle East & Africa Cell & Tissue Preservation Market Value Share Analysis, by End-user, 2020 and 2031
Figure 83: Middle East & Africa Cell & Tissue Preservation Market Attractiveness Analysis, by End-user, 2021–2031
Figure 84: Global Cell & Tissue Preservation Market Share, by Company, 2020
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Cell & Tissue Preservation Market Forecast Report, 2021-2031
